CSIR-Indian Institute of Chemical Technology, has a strong patent portfolio and one of the leading among entire 37 CSIR laboratories. The portfolio covers a wide range of areas in the field of chemical science and technology. CSIR-IICT always emphasizes on quality patent and hence all patent proposals passed through a well formulated scrutiny process. A judicious call is also being taken while selecting the jurisdictions for its protection.
The specific patents held by CSIR-IICT would depend on the particular areas of research and innovation made by its scientists and researchers, either independently or in collaboration with other organizations/industries. Some of the prime areas where CSIR-IICT has filed its patents include pharmaceuticals, agrochemicals, chemical biology, polymers, chemical processes, materials science, and environmental technologies.
CSIR-IICT keep marketing & promotion about its technologies and patents in every possible fora. It has also licensed its patents to several companies for commercialization under different business models. The percentage of patent licensing is quite higher as compared with various other organizations across the globe.
CSIR Reference Number: 0013NF2020
Patent Number: PT-698
Inventor: Saurav Das, Sudip Mukherjee, ChittaRanjanPatra
Applicant: CSIR
Abstract: Present invention relates to a fluorescent bimetallic nanocomposites (M1@M2-NCs) of silver-gold (Ag@Au-NC) and silver-platinum (Ag@Pt-NC) by reducing silver nitrate (AgNO3) on gold nanoparticles (AuNPs) and platinum nanoparticles (PtNPs) using sodium borohydride (NaBH4) at alkaline pH=11, in presence of lysozyme that acts as a template, capping and stabilizing agent. Particularly, present invention relates to biocompatible bimetallic nanocomposites (M1@M2-NCs) having promising multifunctional applications (cell imaging, bio-sensing, therapeutics) observed by both in vitro as well as in vivo experiments. More particularly, present invention relates to fluorescent bimetallic nanocomposites (M1@M2-NCs) of silver-gold (Ag@Au-NC) and silver-platinum (Ag@Pt-NC) useful as an alternative nanomedicine in cancer theranostics applications.
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| PCT | 2020-03-05 | PCT/IN2021/050215 | 0001-01-01 | 0 |
| India,IN | 2018-11-13 | 201811042595 | 0001-01-01 | 0 |
| India,IN | 2020-03-06 | 202011009670 | 0001-01-01 | 0 |
CSIR Reference Number: 0032NF2022
Patent Number: PT-721
Inventor: Namita Santosh Mahadik, Debarata Mukhopadhyay, Rajkumar Banerjee
Applicant: CSIR
Abstract: -
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| India,IN | 2023-03-02 | 202311014137 | 0001-01-01 | 0 |
CSIR Reference Number: 0121NF2022
Patent Number: PT-724
Inventor: Shagufta Haque, Chitta Ranjan Patra
Applicant: CSIR
Abstract: .
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| India,IN | 2022-10-17 | 202211059359 | 0001-01-01 | 0 |
CSIR Reference Number: 0125NF2016
Patent Number: PT-666
Inventor: M. Sujan Kumar, J.Sudhakar, Rajkumar Banerjee
Applicant: CSIR
Abstract: The present invention relates to the development of the cationic progesterone compounds as a novel anti-tumor agent. The present invention provides a method for the preparation of novel series of progesterone derivatives. The invention also provides information related to highly selective anti-cancer activities of these derivatives in wide range of cancer cell irrespective of their progesterone receptor status. Thus, the presently disclosed cationic progesterone compound offers a viable option as anticancer therapeutics.
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| EP | 2017-07-04 | 17179456.3 | 0001-01-01 | 0 |
| United Kingdom,GB | 2017-07-04 | 17179456.3 | 2019-09-25 | 3275888 |
| France,FR | 2017-07-04 | 17179456.3 | 2019-09-25 | 3275888 |
| United States,US | 2017-07-14 | 15/649832 | 2018-10-16 | 10100079 |
| India,IN | 2016-07-28 | 201611025818 | 2020-08-31 | 345726 |
CSIR Reference Number: 0199NF2017
Patent Number: PT-683
Inventor: Kundu Tapas Kumar, Rajkumar Banerjee, Eswaramoorthy Muthusamy, Elechelwar Chandra Kumar, Halder Sinha Sarmistha
Applicant: CSIR
Abstract: The present disclosure relates to a carbon nanospheres based delivery system comprising nanospheres conjugated to folate receptor targeting ligands and carrying an active agent for targeting tumor mass. In an embodiment the present disclosure provides a composition comprising a complex of general formula: CSP-F8-S and method of preparation thereof. The CSP represents a carbon nanosphere; the F8 represents a folate receptor targeting ligand comprising the conjugates of cationic lipid with folic acid or derivative thereof; and S represents an active agent, wherein the CSP are conjugated with the F8; and CSP-F8 conjugates are covalently or non-covalently linked with the active agent S. The composition shows ability to target and kill both TEC and TAM, thereby exhibiting dual targeting strategy for effective tumor regression.
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| India,IN | 2021-03-31 | 202111015505 | 0001-01-01 | 0 |
| India,IN | 2018-03-13 | 201841009113 | 0001-01-01 | 0 |
CSIR Reference Number: 0199NF2020
Patent Number: PT-707
Inventor: Madhan Mohan Chandra, Sekhar Jaggarapu, Eswaramoorthy Muthusamy, Tapas K Kundu, Rajkumar Banerjee
Applicant: CSIR
Abstract: The present invention describes the development of a novel, tumor epithelial cell and tumor- associated macrophage (TAM)-targeting, blood brain barrier (BBB) crossing glucose-based nanospheres (CSP). For targeted killing of tumor cells and TAM within glioma tumor milieu, CSP is tagged with sigma receptor (SR)-targeted ligand H8 to form CSP-H8 or CH8. H8 molecule is earlier developed from neuropsychotic drug haloperidol (HP) by conjugating cationic lipid to HP. H8 is an anti-proliferative agent that kills SR-expressing tumor cells. CH8 exhibits effective reduction of brain associated tumor lesions and increased survivability of in situ glioma bearing mice.. The product thus shows CSP-based dual strategy of targeting and killing pro-tumorigenic, SR-expressing tumor associated cells and exemplifies repurposing of neurophyschotic drugs for treating brain tumor.
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| PCT | 2022-03-29 | PCT/IN2022/050317 | 0001-01-01 | 0 |
CSIR Reference Number: 0202NF2016
Patent Number: PT-671
Inventor: K.Rajesh, Sudip Mukherjee, ChittaranjanPatra, Vijay Gopal
Applicant: CSIR
Abstract: The current invention relates to development of new formulation containing gold nanoparticles (AuNPs) with bi-functional recombinant fusion proteins TRAF(C) for the delivery of anticancer drugs and nucleic acids to HER2+ cancers. Using the combinatorial approach,gold nanoparticle-based targeted drug delivery system (TDDS) or (Au-TR-DX-si) has been developed by combining AuNPs with bi-functional recombinant fusion protein TRAF(C) (TR), doxorubicin (DX) and siRNA (si).In addition, the engineered fusion protein TRAF(C) has the ability to target selectively to HER2+ receptors (heregulin receptors also, known as human,epidermal growth factor, receptor-2) overexpressed in ovarian cancer cells (SK-OV-3). The functional activity of the nanoformulation was further evaluated both in vitro and in vivo. Intraperitoneal administration of this formulation in SK-OV-3 xenograft nude mice exhibited significant suppression of tumor growth due to co-delivery of ErbB2 siRNA and doxorubicin. In vivobiodistribution confirmed increased accumulation of gold in tumor tissue which further established the targeting property of the nanoconjugation. Based on these studies, we strongly believe that the nanomedicine-based formulation could be developed as a universal strategy for effective treatment of HER2+ cancers.
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| PCT | 2017-10-23 | PCT/IN2017/050488 | 0001-01-01 | 0 |
| India,IN | 2016-10-25 | 201611036499 | 0001-01-01 | 0 |
| United States,US | 2019-04-24 | 16/344519 | 2020-10-20 | 10806715 |
CSIR Reference Number: 0223NF2019
Patent Number: PT-695/A
Inventor: Kotamraju Srigiridhar, BathulaSurendar Reddy, Sistla Ramakrishna, Addlagatta Anthony, ThennatiRajamannar, Shaik Altab, Jungum Aruna, Sangaraju Rajendra, Neeli Praveen kumar, MadhusudhanaKuncha
Applicant: CSIR
Abstract: The present invention relates to compound for treating a wound, promoting hair growth around the wound and/or minimizing the scar of a wound and also for the treatment of psoriasis. The invention also relates to a method for treating a wound, promoting hair growth on and/or around the wound area and/or minimizing the scar of a wound and also for the treatment of psoriasis by topical application of the compound.
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| PCT | 2020-11-23 | PCT/IB2020/061043 | 0001-01-01 | 0 |
| Argentina,AR | 2020-11-20 | 1189018 | 0001-01-01 | 0 |
| Taiwan, Province of China,TW'] | 2020-11-23 | 109141014 | 0001-01-01 | 0 |
| India,IN | 2019-11-22 | 201911047906 | 0001-01-01 | 0 |
CSIR Reference Number: 0275NF2014
Patent Number: PT-639
Inventor: K Srigiridhar, K Santosh, V Satishbabu, T Pavankumar, B V Subba Reddy, Mahesh Kumar J
Applicant: CSIR
Abstract: The present invention relates to an antioxidant compound having anti atherosclerotic effect and preparation thereof. It more particularly relates to the synthesis of TPP+ coupled esculetin (mitochondria-targeted esculetin [Mito-Esc]) followed by the biological evaluation of Mito-Esc for its ability to attenuate Angiotensin-II-induced atherosclerosis in apolipoproteinE Knockout mice along with the endothelial cell age-delaying effects of Mito-Esc
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| United Kingdom,GB | 2016-02-19 | 2016357.2 | 0001-01-01 | 0 |
| United Kingdom,GB | 2016-02-19 | 1602930.8 | 2020-12-02 | 2540234 |
| United States,US | 2017-02-27 | 15/443538 | 2018-05-08 | 9963476 |
| United States,US | 2016-02-19 | 15/047872 | 2017-02-28 | 9580452 |
| India,IN | 2015-02-19 | 0478/DEL/2015 | 2020-05-29 | 337658 |
CSIR Reference Number: 0295NF2015
Patent Number: PT-655
Inventor: M.Vijaysagar, Arabindachaudhuri, D.Mukhopadhyay
Applicant: CSIR
Abstract: The present invention discloses a Plectin-1 receptor targeting novel cationic KTLLPTPK-lipopeptide. The present invention further discloses a liposomal formulation comprising the cationic KTLLPTPK-lipopeptide, at least two co-lipids, at least one chemotherapeutic agent and a pharmaceutically acceptable carrier. The present invention also provides a method for regressing established pancreatic tumors comprising administering therapeutically effective amount of the liposomal formulation with the chemotherapeutic agent in combination with targeted genetic immunization (DNA vaccination) i.e. by immunizing mice with electrostatic complexes (direct in- vivo DC-targeting cationic liposomes) of DNA
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| United States,US | 2017-03-16 | 15/460701 | 2020-04-07 | 10611796 |
| India,IN | 2016-03-16 | 201611009088 | 2021-05-21 | 368021 |
CSIR Reference Number: 0001NF2021
Patent Number: PT No: PT-708
Inventor: Sutapa Ghosh, Sunil Mishra, Sistla Ramakrishna, Akshaya Raghavan, SuprabhatSarkar
Applicant: CSIR
Abstract: -
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| India,IN | 2021-09-29 | 202111044178 | 0001-01-01 | 0 |
CSIR Reference Number: 0043NF2017
Patent Number: PT No: PT-677
Inventor: L.Giribabu, N.Vamsi Krishna, J. V. S. Krishna
Applicant: CSIR
Abstract: The present invention relates to the design of a series of efficient and durable porphyrin based sensitizers by using donor-π-acceptor (D-π-A) approach having ethynyl bridge between donor and porphyrinmacrocycle to broaden the absorption spectrum dye-sensitized solar cells applications and in liquid I-/I3-redox couple and these sensitizers have shown conversion efficiency of 6.17 to 10.20%. The main advantage for the introduction of a triple bone between donor and π-spacer prophyrin is to get the broad absorption from UV region to near-IR region of absorption spectra, which belongs to rare class of sensitizers.
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| India,IN | 2017-03-10 | 201611008487 | 2022-04-21 | 395195 |
CSIR Reference Number: 0067NF2017
Patent Number: PT No: PT-678
Inventor: Surya Prakash Singh, T. Gayathri, K. Srigiridhar, K. Santosh
Applicant: CSIR
Abstract: The present invention relates to design and synthesis of dyes having BODIPY core for tracking mitochondria. We have disclosed six novel Borondipyrromethenefluorochromes. Tailored with phenoxymethylpyridine, among six, three derivatives showed excellent solubility in water apart from organic solvents. Mild reaction conditions were adapted to prepare the targeted derivatives. These dyes have great potential as mitotrackers and costs lesser than those of commercial ones.
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| India,IN | 2017-05-24 | 201711018190 | 2021-07-06 | 371195 |
CSIR Reference Number: 006TM2022
Patent Number: PT-729
Inventor: D. Shailaja
Applicant: CSIR
Abstract: -
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|
CSIR Reference Number: 0176NF2022
Patent Number: PT-726
Inventor: Vadthya Raju, Pratyay Basak, Jetti Vatsala Rani
Applicant: CSIR
Abstract: -
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| India,IN | 2022-09-28 | 202211055811 | 0001-01-01 | 0 |
CSIR Reference Number: 0274NF2014
Patent Number: PT-638
Inventor: S.Palaniappan, G.Ramesh
Applicant: CSIR
Abstract: This invention relates to polyaniline coated electrode. Polyaniline salt solution was coated on current collector and purified with organic solvent, which acts as electrode for supercapacitor. More particularly, polyaniline salt is capable of providing an active substance for high performance polarizable electrode.
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| India,IN | 2016-08-16 | 201811030628 | 0000-00-00 |
CSIR Reference Number: 0018NF2018
Patent Number: PT-686
Inventor: H.M. Sampat Kumar, B.Srinivas Reddy, L.Ravi Shankar
Applicant: CSIR
Abstract: Present invention relates to a uttrosidesaponin based immune-adjuvant/potentiator composition useful for human and veterinary vaccines, comprising immunostimulatory molecules selected from uttroside A, uttroside B or a combination thereof and at least one antigen. It also discloses uttrosidesaponin based immune-adjuvant/potentiator composition is oil-in-water nano emulsion and in nanoparticulate from.
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|
CSIR Reference Number: 0019NF2019
Patent Number: PT-688
Inventor: Srivari Chandrasekhar, Subhash Ghosh, Avula Shiva Krishna, Chada Raji Reddy, Gangarajula Sudhakar, Kumaraguru Thenkrishnan, Srihari Pabbaraja, Prathama Satyendra Mainkar, Rajesh Nasam
Applicant: CSIR
Abstract: The present invention relates to an enzymatic process for preparation of optically pure enantiomers of homopropargylic alcohol compounds of formula I, which are useful intermediates for the synthesis of Halichondrin B and analogs. OH ,OPwherein, P is H or an alcohol protecting group, n is an integer ranging from 0-12.
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| PCT | 2020-06-17 | PCT/IN2020/050533 | 0001-01-01 | 0 |
| India,IN | 2019-06-21 | 201911024666 | 0001-01-01 | 0 |
| Japan,JP | 2021-12-21 | 2021-576357 | 0001-01-01 | 0 |
| United States,US | 2021-12-21 | 17/621052 | 0001-01-01 | 0 |
CSIR Reference Number: 0033NF2022
Patent Number: PT-722
Inventor: KumaraguruThenkrishnan, GurralaSheelu
Applicant: CSIR
Abstract: -
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| India,IN | 2022-04-18 | 202211022882 | 0001-01-01 | 0 |
CSIR Reference Number: 0044NF2022
Patent Number: PT-723
Inventor: PrathamaSatyendraMainkar, Srivari Chandrasekhar, Kiranmai Nayani, Srihari Pabbaraja, Chandra Shekhar, Rajesh Nasam, Siva Ramakrishna Paipuri, Prakash Kumar
Applicant: CSIR
Abstract: -
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| India,IN | 2022-03-30 | 202211019417 | 0001-01-01 | 0 |
CSIR Reference Number: 0047NF2020
Patent Number: PT-702
Inventor: Srihari Pabbaraja, Ajay Kumar Singh, Vinay Kumar Sthalam, BhushanMahajan
Applicant: CSIR
Abstract: The present invention relates to an integrated continuous flow process for active pharmaceutical ingredients (API) of formula I. Particularly, present invention relates to a process for multi-operational, without intermediate purification and solvent exchange synthesis process for active pharmaceutical ingredients (API) of formula I.
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| India,IN | 2020-07-10 | 202011029345 | 0001-01-01 | 0 |
CSIR Reference Number: 0063NF2019
Patent Number: PT-693
Inventor: Ajay Kumar Singh, P. Srihari, Subhash Ghosh, Bhushan Mahajan, TaufiqahmedMujawar
Applicant: CSIR
Abstract: The present invention relates to a process involving continuous micro-electro-flow reactor system for ultra-fast, oxidant free, C-C coupling reactions for the synthesis of symmetrical biaryls and analogs thereof general formula 1. This invention further relates to the said process for preparation of antiviral drug daclatasvir.
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| United States,US | 2020-04-01 | 16/837070 | 0001-01-01 | 0 |
| India,IN | 2019-05-02 | 201911017478 | 0001-01-01 | 0 |
CSIR Reference Number: 0084NF2020
Patent Number: PT-704
Inventor: Ajay Kumar Singh, Srihari Pabbaraja, Deepak Kumar Jaiswal, Dnyaneshwar Aand, AbhilashRana
Applicant: CSIR
Abstract: An automated apparatus (Diazo-M-pen and Diazo-M-cube) for production, utilization and quenching of highly toxic diazomethane comprising of integrated pumps, tubular flow reactor, liquid-liquid micro-separator, solid MOF quencher etc.
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| PCT | 2021-08-24 | PCT/IN2021/050811 | 0001-01-01 | 0 |
| India,IN | 2020-08-24 | 202011036463 | 0001-01-01 | 0 |
CSIR Reference Number: 0105NF2019
Patent Number: PT-694
Inventor: GangarajulaSudhakar, NagamSatish, Tella Ramesh Babu, KumaraveluJagavelu, Himalaya Singh, Mohammad Imran Siddiqi, Muhammad Wahajuddin, Sandeep Kumar Singh, Mamunur Rashid, Anil Kumar KarunakaranSasikala
Applicant: CSIR
Abstract: The present invention relates to azirine containing compounds useful as anti-angiogenesis agents and preparation thereof. Particularly the present invention relates to azirine containing compounds of formula I Formula I wherein R1 is selected from alkyl (C1-C12); alkenyl (C1-C12), hydroxy, nitro, halogen, amino, cyano, aryl, heteroaryl, cycloalkyl (C1-C7), cyclo ether (C1-C6), heteroalkyl, alkoxy, alkylamino, aryl amino, alkyl (C1-C12) ester, (hetero)aryl ester, alkyl phosphonate, (hetero)aryl phosphonate, tetrazole; R2 and R3 are either same or different and selected from the group consisting of H, COOR4, cyano, tetrazole, phosphonate, alkoxybenzyl, hydroxy, nitro, halogen, amino, alkyl (C1-C12), aryl, heteroaryl, cycloalkyl (C1-C7), heteroalkyl, alkoxy, alkylamino, aryl amino, (hetero)aryl ester, alkyl phosphonate, (hetero)aryl phosphonate or tetrazole; wherein each of these groups [R1, R2 and R3] may further substituted with one or more substituents selected from the group consisting of hydrogen, hydroxy, halogen, cyano, alkyl amino, aryl amino, alkoxy, amino, nitro, aldehyde, carboxylic acid, ester or phosphoester, (hetero)aryl; or 5-7 membered hetrocyclic ring wherein hetroatom is O, N or S, R4 is selected from the group consisting of alkyl (C1-C12), allyl, Methoxyethyl; benzyl; R5 R6 and R7 are either same or different and selected from the group consisting of H, OMe; H, CH3, t-butyl; Halogen (Cl, Br, F, I), OCF3, CN, OBu, vinyl; dimethylamino or R5 and R6 may be joined to form a 5 to 6 membered hetrocyclic ring.
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| PCT | 2021-06-04 | PCT/IN2021/050544 | 0001-01-01 | 0 |
| India,IN | 2020-06-04 | 202011023422 | 0001-01-01 | 0 |
CSIR Reference Number: 0129NF2021
Patent Number: PT-715
Inventor: Halmuthur Mahabalarao Sampath Kumar, Bonam Srinivasa Reddy, Paturu Rama Subba Reddy, AtlaSandeep
Applicant: CSIR
Abstract: -
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| India,IN | 2020-02-25 | 202211011022 | 0001-01-01 | 0 |
CSIR Reference Number: 0150NF2020
Patent Number: PT-705
Inventor: Srivari Chandrasekha, Prathama S Mainkar, ChadaRaji Reddy Sistla Ramakrishna, Andugulapati Sai Balagi, Kuncha Madhusudana, Muppidi Mohan Venkata Subbarao, TirunavalliSatya Krishna.
Applicant: CSIR
Abstract: The present invention relates to compound of Formula 1 for use in treating IPF, by reducing collagen deposition in lungs, attenuating the fibrotic marker's expression (in IPF cell-lines Bleomycin induced rat lungs) and improving the bleomycin induced pathological changes in rat lungs, and ARDS, by reducing the cytokine storm. The invention also relates to compound of Formula 1 for use in treating various fibrotic disorders like lung injuries caused by virus or bacterial infections, cardiac, hepatic and kidney fibrosis.
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| PCT | 2021-09-03 | PCT/IN2021/050851 | 0001-01-01 | 0 |
| India,IN | 2020-09-05 | 202011038497 | 0001-01-01 | 0 |
CSIR Reference Number: 0151NF2013
Patent Number: PT-619
Inventor: C. Ganesh Kumar, P.Sujitha
Applicant: CSIR
Abstract: The present invention relates to polymeric biosurfactants isolated from two bacterial strains of Microbacterium sp. strain BS-2 [MTCC 5822] and Brevibacillus sp. strain BS-207 [MTCC 5823]. The present invention relates to an acidic exopolysaccharide (EPS), termed Microsan, with chemical composition of glucose, mannose and glucuronic acid (β-D-glucuronyl-(1-2)-D-mannosyl-(1-4)-D-glucose) produced by Microbacterium sp. strain BS-2 and a neutral EPS, termed Brevisan, of galactomannan with galactose and mannose residues in the ratio of 1:1 produced by Brevibacillus sp. strain BS-207. Both these polysaccharides exhibited surface-active and potential antibacterial, antioxidant, anti-inflammatory,
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| EP | 2019-01-08 | 19150824.1 | 0001-01-01 | 0 |
| EP | 2015-03-31 | 15162029.1 | 2019-01-09 | 2947153 |
| Germany,DE | 2015-03-31 | 15162029.1 | 2019-01-09 | 2947153 |
| United Kingdom,GB | 2015-03-31 | 15162029.1 | 2019-01-09 | 2947153 |
| France,FR | 2015-03-31 | 15162029.1 | 2019-01-09 | 2947153 |
| United States,US | 2015-05-01 | 14/676117 | 2018-10-23 | 10106627 |
| India,IN | 2014-04-01 | 939/DEL/2014 | 0000-00-00 |
CSIR Reference Number: 0163NF2018
Patent Number: PT-687
Inventor: P. Srihari, Ajay K Singh, S. Vinay Kumar
Applicant: CSIR
Abstract: The present invention relates to preparation of pyrazoles. This invention further relates to a continuous flow micro-total process system for preparation of celecoxib, a COX-2 selective non-steroidal anti-inflammatory drug, and analogs thereof.
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| PCT | 2020-01-27 | PCT/IN2020/050088 | 0001-01-01 | 0 |
| EP | 2021-07-14 | 20747897.5 | 0001-01-01 | 0 |
| United States,US | 2021-07-29 | 7/426906 | 0001-01-01 | 0 |
| United Kingdom,GB | 2021-07-14 | 20747897.5 | 0001-01-01 | 0 |
| India,IN | 2019-02-01 | 201911004015 | 0001-01-01 | 0 |
CSIR Reference Number: 0174NF2022
Patent Number: PT-727
Inventor: Halmuthur Mahabalarao, Sampath Kumar, Talati Mamta Natvarlal, Vemireddy Sravanthi, Guruprasad R Medigeshi
Applicant: CSIR
Abstract: -
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| India,IN | 2022-10-21 | 202211060662 | 0001-01-01 | 0 |
CSIR Reference Number: 0184NF2019
Patent Number: PT-696
Inventor: SrihariPabbaraja, Goverdhan Mehta, Shweta Singh
Applicant: CSIR
Abstract: The present invention relates to quinolones of formula (I) and process for it’s preparation by amine insertion into aryl-ynones thereof. The invention further relates to the process to obtain the natural products such as: graveoline, graveolinine, pseudane IV, pseudane VII, pseudane VIII and pseudane XII. The invention also describes the process for the total synthesis of waltherione F in concise approach from the quinolone synthesized.
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| PCT | 2020-08-16 | PCT/IN2021/050790 | 0001-01-01 | 0 |
| India,IN | 2020-08-22 | 202011036288 | 0001-01-01 | 0 |
CSIR Reference Number: 0185NF2022
Patent Number: PT-728
Inventor: Ajay Kumar Singh, Subhash Ghosh, Srihari Pabbaraja, Ruchi Chauhan, Abhilash Rana
Applicant: CSIR
Abstract: -
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| India,IN | 2023-02-06 | 202311007990 | 0001-01-01 | 0 |
CSIR Reference Number: 0192NF2022
Patent Number: PT-730
Inventor: G Sudhakar, C Ramu, T Kumaraguru, Haridas B Rode, M Sridhar Reddy, CH Raji Reddy, Subhash Ghosh
Applicant: CSIR
Abstract: -
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| India,IN | 2022-11-25 | 202211068208 | 0001-01-01 | 0 |
CSIR Reference Number: 0228NF2021
Patent Number: PT-719
Inventor: Ajay Kumar Singh, Srihari Pabbaraja, AbhilashRana
Applicant: CSIR
Abstract: -
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| India,IN | 2021-01-30 | 202311006039 | 0001-01-01 | 0 |
CSIR Reference Number: 0283NF2015
Patent Number: PT-652
Inventor: Prathama S Manikar, K. Sugnanasundar, T.Pavankumar S. Chandrasekhar
Applicant: A PROCESS FOR THE PRAPRATION OF NICOTINE.
Abstract: The invention relates to a process for the preparation of racemic nicotine from 3- pyridylaldehyde using a one-pot or step-wise method. The process comprises the following steps: Stetter reaction, reduttion-cyclisation and methylation.
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| PCT | 2017-01-06 | PCT/IN2017/050007 | 0001-01-01 | 0 |
| EP | 2018-08-02 | 17707968.8 | 2020-03-25 | 3400219 |
| Belgium,BE | 2018-08-02 | 17707968.8 | 2020-03-25 | 3400219 |
| Switzerland,CH | 2018-08-02 | 17707968.8 | 2020-03-25 | 3400219 |
| Germany,DE | 2018-08-02 | 17707968.8 | 2020-03-25 | 3400219 |
| United Kingdom,GB | 2018-08-02 | 17707968.8 | 2020-03-25 | 3400219 |
| France,FR | 2018-08-02 | 17707968.8 | 2020-03-25 | 3400219 |
| United States,US | 2018-07-06 | 16/068464 | 2021-09-24 | 10421739 |
| India,IN | 2016-01-08 | 201611000697 | 2020-11-24 | 352127 |
CSIR Reference Number: 0016NF2020
Patent Number: PT-700
Inventor: NakkaLingaiah, PiyusaPriyadarsanPattanaik, PendemChandrashekar
Applicant: CSIR
Abstract: Mixed oxides consist of alkaline earth metals are solid base catalysts for the continuous esterification of glycerol with dimethyl carbonate to prepare glycerol carbonate has been disclosed herein. The catalyst comprising of alkaline earth metal oxides with 3:1 to 1:3 molar ratio. The catalyst contains suitable number of basic sites required for the continuous transesterification glycerol to prepare glycerol carbonate at atmospheric pressure under moderate reaction temperature. The optimum reaction conditions were established on selected catalyst. The disclosed catalyst is easy to prepare and stable for continuous operation of the reaction toward the synthesis of glycerol carbonate.
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| India,IN | 2020-03-18 | 202011011627 | 0001-01-01 | 0 |
CSIR Reference Number: 0040NF2021
Patent Number: PT-710
Inventor: NakkaLingaiah, ChennaSumana, PakaRajitha, Peddagorla Mahesh Kumar, Pendem Chandrasekhar
Applicant: CSIR
Abstract: The present invention discloses a process for preparation of (3R, 5 4R)-1-Benzyl-N-4-Dimethylpiperidin-3-Amine. The present invention further discloses novel compounds are selected from (S)-1-benzyl-4-methyl-1,2,3,6-tetrahydropyridin-3-ol (4), (S)-1-benzyl-4-methyl-1,2,3,6-tetrahydropyridin-3-yl 2,2,2-trichloroacetimidate (5) and (R)-N-(1-benzyl-4-methyl-1,2,3,6-tetrahydropyridin-3-yl)-2,2,2-trichloroacetamide (6).
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| India,IN | 2021-10-20 | 202111047811 | 0001-01-01 | 0 |
CSIR Reference Number: 0136NF2021
Patent Number: PT-717
Inventor: Nakka Lingaiah, Rohit Kumar Rana, Peddagorla Mahesh Kumar, Nitin Kumar Labhasetwar, Sunit Kumar Singh
Applicant: CSIR
Abstract: -
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| India,IN | 2021-08-13 | 202111036983 | 0001-01-01 | 0 |
CSIR Reference Number: 0055NF2021
Patent Number: PT-711
Inventor: Malluri Siva Naga Sai, Debiparna De, BankupalliSatyavathi
Applicant: CSIR
Abstract: The invention details the comprehensive continuous production and simultaneous purification of the platform chemical furfural from pentosan rich agricultural residues using a dual catalytic and solvent media composed of naturally occurring hydrogen bond donors and acceptors through a reactive stripping technique using nitrogen as a novel stripping agent thereby posing several advantages such as higher yields, excellent product profile and lower energy consumption over previously adopted production methods.
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| India,IN | 2021-06-03 | 202111024754 | 0001-01-01 | 0 |
CSIR Reference Number: 0064NF2019
Patent Number: PT-692
Inventor: A. Seshu Kumar, N. Chandra Shekar, SarikaPhani Raghu, G. Subrahmanyam
Applicant: CSIR
Abstract: This invention is about the development of a vegetable oil extraction method using mechano-chemical route; first, the moisture content of the oilseeds is adjusted to the required level through drying process; the dried seeds are subjected to comminution by suitable mechanical means to a desired particle size; further a predetermined percentage of volatile alkali is added and soaked for a predetermined time; this is followed by mechanical fractionating to separate the solid fraction and the liquid fraction; the liquid fraction is water washed to remove the added volatile alkali and the impurities if any; the water washed liquid fraction is subjected to liquid-liquid separation to separate the oil phase and the water phase; the solid fraction is dried using heating at a temperature little over ambient to remove the acquired moisture in the process and the traces of added volatile alkali; the oil phase and the dried solid fraction are the desired products and the water phase can be re-concentrated and reused.
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| China,CN | 2021-07-20 | 202010697429.6 | 0001-01-01 | 0 |
| India,IN | 2019-07-18 | 201911028912 | 0001-01-01 | 0 |
CSIR Reference Number: 0130NF2021
Patent Number: PT-716
Inventor: Sundergopal Sridhar, Sugali Chandra Sekhar, NiveditaSahu, Bukke Vani, Manideep Pabba, Fatima Saeed, AartiTallam, Sai Kishore Butti
Applicant: CSIR
Abstract: The present invention relates to the design of a face mask that incorporates a waste derived warp knit polyethylene terephthalate (PET) permeate spacer layer for daily usage in current pandemic conditions. The central layer in the face masks is a selective hydrophobic layer that is recycled from waste RO membrane modules and is intended for usage as a non-medicated multi-layered face mask for common man. The mechanical strength and shape holding capability enables the preparation of the face mask in a unique 3D shape that extends from the nose bridge to the chin, leaving an air gap between the mouth and the inner layer of the face mask. Design advantage obtained by the incorporation of the PET layer enables smooth facial movements and hindrance free speaking. The 3D folding feature of the mask is seamless and fits snug on the user’s face that which prevents spectacle fogging and chances of infections.
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| PCT | 2022-05-23 | PCT/IN2022/050483 | 0001-01-01 | 0 |
| India,IN | 2021-08-19 | 202111037989 | 0001-01-01 | 0 |
CSIR Reference Number: 0161NF2022
Patent Number: PT-725
Inventor: Bhoga Arundhathi, Sajja S Chandrasekhar, Sai Kishore Butti, Badhra Chalam Narkuti, Mamila Shyam Sunder, Madhupati Madhumala, Nivedita Sahu, Sugali Chandra Sekhar, Sundergopal Sridhar.
Applicant: CSIR
Abstract: -
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| India,IN | 2022-12-14 | 202211072433 | 0001-01-01 | 0 |
CSIR Reference Number: 0173NF2016
Patent Number: PT-668
Inventor: M. Pradeep Kumar, K. Ravindranath, M.Radha Krishna, U.Ashutosh R. ShobhaPathak, G. Vijaya Murthy, T. Srinivasan, G.Veeraiah M. Shyam Sunder, V. Uma Maheshwara Sarma, Y.Parthasaradhy Sunil Sinha, M. Ba
Applicant: CSIR, GACL
Abstract: An improved process for the production of concentrated aqueous solutions of hydrazine hydrate by ketazine method is described. In particular, it describes preparation of hydrazine hydrate by ketazine method using 50-70% hydrogen peroxide, recyclable solid acetamide and ammonium acetate activator for ketazine formation and catalyst free hydrolysis of ketazine to give aqueous solutions of hydrazine hydrate in energy efficient manner.
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| PCT | 2017-09-28 | PCT/IN2017/050431 | 0001-01-01 | 0 |
| United States,US | 2019-03-20 | 16/335225 | 0001-01-01 | 0 |
| India,IN | 2016-10-03 | 201611033667 | 2021-10-05 | 378643 |
CSIR Reference Number: 0183NF2017
Patent Number: PT-680
Inventor: S. Sridhar, M. Madhumala, Y.V.L. Ravi Kumar, Siddhartha Moulik,NiveditaSahu, Saranya Ramesh Kumar, Dileep Kumar Fothedar
Applicant: CSIR
Abstract: The present invention discloses the compact design of low-cost membrane process for the production of demineralized (DM) water. The demineralization process in the present invention is related to the cascaded high-flux and high-selective membrane system for hyper permeation which is operated under the pressure of 3-7 kg/cm2 to generate DM water with total dissolved solids (TDS) of 0-2 ppm, with the option of post treatment by a mixed bed ion exchange resin column for further enhancement in resistivity of the ultrapure water. The present invention of DM water system is designed for a capacity in the range of 25-70 L/h capacity and its salient features include compact design of the membrane assembly with higher effective membrane area per unit volume to ensure higher DM water recovery at relatively lower pressure compared to the existing reverse osmosis (RO) membrane system. The process pertaining to the present invention is more economical and effective compared to the conventional demineralization processes and also the more expensive demineralization membrane units currently available in the market. The embodiment of the present invention is related to the compact and efficient configuration of the membrane modules for DM water production useful for several biotechnological, biochemical, medical and industrial applications.
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| India,IN | 2017-10-25 | 201711037739 | 0001-01-01 | 0 |
CSIR Reference Number: 0194NF2020
Patent Number: PT-706
Inventor: Siddhartha Moulik, Pavanii Vadthya, S.Venkata Mohan, AditiMullick
Applicant: CSIR
Abstract: The present invention relates to the design and development of a hydrodynamic cavitation based reactor for processing of liquid food products to extend the shelf life with better taste and nutritional quality. The cavitation reactor comprises of a stator-rotor arrangement where the cavitator is fixed with a shaft to rotate and the outer jacket is fixed. The rotating cavitator has been designed at two different configurations; one having a hyperbolic dumbbell like shape with multiple in-depth indentations made on the surface for creating pressure drop and the other is in a tapered cylindrical shape with multiple holes grooved on the surface for causing pressure drop and cavitation bubble formation. . The CFU test was carried out to see the impact of treatment on spoilage bacterial growth. Also the changes in physicochemical properties and major metabolites present in the coconut water were measured through NMR study before and after treatment. The entire assembly provides an attractive and potential route for non-thermal sterilization of various liquid food products without much complicacy in the design and that can be easily retrofitted to any existing food processing industrial operations.
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| India,IN | 2020-11-25 | 202011051434 | 0001-01-01 | 0 |
CSIR Reference Number: 0213NF2019
Patent Number: PT-697
Inventor: Pavanii Vadthya, Siddhartha Moulik
Applicant: CSIR
Abstract: An electrolyser and method of the present invention comprises electrodes made of titanium with perforations, arranged parallel and equidistant from the center of an electrolytic ionized water producer. An inlet is provided to the ionizer at centre of electrodes on the top position. All the parallel electrodes are enclosed leak proof in a rectangular container with two outlets on opposite sides and electrical connections from variable power supply source to the device. The water is introduced into the centre of the ionizer from the top. The charged electrodes ionize the water and produce alkaline ionized water at cathode and acidic ionized water at anode. Acidic ionized water and alkaline ionized water are collected separately from the electrolyser.
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| PCT | 2021-05-26 | PCT/IN2021/050512 | 0001-01-01 | 0 |
| India,IN | 2020-07-03 | 202011028347 | 0001-01-01 | 0 |
CSIR Reference Number: 0008NF2022
Patent Number: PT-720
Inventor: Katragadda Suresh Babu, Bandi Siva, Kummari Narender, Halmathur Mahabalarao Sampath Kumar
Applicant: CSIR
Abstract: -
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| India,IN | 2022-05-17 | 202211028459 | 0001-01-01 | 0 |
CSIR Reference Number: 0029NF2016
Patent Number: PT-659
Inventor: A. Gangagni Rao, K. Kranti, G. Bharath, Sameena Begum Y.V. Swamy
Applicant: A. Gangagni Rao, K. Kranti, G. Bharath, Sameena Begum Y.V. Swamy
Abstract: The present invention provides a sequential high rate acidogenic anaerobic reactor (100) incorporating pre-treatment process (SHAARP) for production of mixture of bioethanol and VFA by treatment of the organic waste. It uses the sugars and COD available in the organic waste. SHAARP is a horizontal plug flow digester with different compartments and baffles allowing the slurry to flow across the digester. In each compartment of the digester important chemical and microbial reactions viz: thermal acidic hydrolysis, microbial anaerobic acidogenesis takes to yield the final product either mixture of bio-ethanol and VFA or VFA based on the characteristics of the organic solid waste. CO2 generated in the digester is reused for mixing as well as acidification of the digester for higher yield of desired product.
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| India,IN | 2017-07-11 | 201711024332 | 0001-01-01 | 0 |
CSIR Reference Number: 0231NF2022
Patent Number: PT-731
Inventor: Anupoju Gangagni Rao, Anupoju Begum, Vijayalakshmi Arelli, Sudharshan Juntupally, Naveen Kumar, Mamindlapelli, Parmeshwar Patil, Vivek Rathore, Jaya Rawat, Anurag Singh
Applicant: CSIR
Abstract: -
Details:
| Countries | Filling Date | Application No. | Grant Date | Grant No |
|---|---|---|---|---|
| India,IN | 2023-03-07 | 202311015544 | 0001-01-01 | 0 |
